Everything You Need to Know About ICIs in Gynecologic Cancers

Everything You Need to Know About ICIs in Gynecologic Cancers

Join Dr. Yeku for a discussion on novel and emerging immunotherapeutic regimens for the management of gynecologic cancers.

 

The goal of this activity is to explore and understand the rationale and current and potential role of immunotherapy in the treatment of gynecologic cancers.

 

This activity is intended for oncologists, obstetricians, gynecologists, and pathologists.

 

 

 

 

Learning Objectives:

  • Have increased knowledge regarding the
    • Clinical trial data around the use of immune checkpoint inhibitor (ICI) regimens in women with gynecological cancers
    • Role of immunotherapeutic biomarkers in women with gynecological cancers
    • Patients with gynecological cancer in whom an immune checkpoint inhibitor regimen should be considered

 

Approximate Time to Complete: 30 minutes

 

Credit Available: April 8, 2021 - April 8, 2022

 

Developed through a partnership between SITC and Medscape.

sitc_log_color.png     

Medscape_EDU-RGB-2x-300.png

 

 

Additional Resources for Clinicans from SITC:

 

 

Accreditation Council for Continuing Medical Education (MD/DO)
AMA PRA Category 1 Credit(s)™: 0.50
Accreditation Council for Continuing Medical Education and ABIM Maintenance of Certification
AMA PRA Category 1 Credit(s)™ / ABIM Maintenance of Certification Part 2 Credit: 0.50